The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. - Wikidata - awgldk - TriplyDB

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

http://www.wikidata.org/entity/Q34015778

about

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Epigenetic Modulators of Monocytic Function: Implication for Steady State and Disease in the CNS Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy HDAC inhibitors and immunotherapy; a double edged sword?Histone deacetylases as targets for treatment of multiple diseases Current and emerging strategies for the prevention of graft-versus-host disease Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages Genetics and epigenetics of rheumatoid arthritis Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children Prospects for treatment of latent HIV.Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.Detection of gene expression in an individual cell type within a cell mixture using microarray analysis.Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Transcriptome analysis revealed unique genes as targets for the anti-inflammatory action of activated protein C in human macrophages.Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation.Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes.Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production.Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo Differences in signaling pathways by IL-1beta and IL-18.Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

P2860

Q24288997-FE1C904E-4C7D-413B-AB53-766956847DD9 Q24796904-AD0F431B-3533-4D1A-B6EF-1C96047D409C Q24816674-246F14AE-EF8E-460D-9A25-E9AD2899127D Q26739120-04452EC8-793E-4BF9-A5A8-E8CB350DDC19 Q26768497-A20D2297-04C9-4652-81DB-68C8F60A9C8D Q26770391-6DAD48CB-C7B1-42D6-8B9D-7A289CAEF95A Q26772718-67738F20-0A31-4027-9402-FF0DED231AED Q26783032-CFD550F6-5754-4071-A367-F3E2CACA2AF8 Q26853102-81300F97-872E-4A06-937A-573D2B830598 Q27000389-163DEB33-FC4F-46FF-91B6-FC3A136D2DB4 Q27016541-215C2E90-2564-4514-B056-AAD66ADA8684 Q27324527-72760140-1D62-47C4-9DB9-B9B196987139 Q27327201-C2B5CDB3-483D-4B5D-87C2-AC4C35ABFCCF Q28076052-98B507BE-B129-4AFD-B014-211246D6BBBC Q28294510-B35D841E-58FD-47F3-A6E2-4D366461032A Q28534348-F6E23290-4028-4846-89B2-3572EE7A816E Q28575131-69C27B88-3A51-4BF4-94A5-F2347BFBD421 Q30424413-C97C1CD3-B3DA-41FF-826F-87EC11F3B528 Q30524207-0B7E6CFB-F3EA-4345-BD2C-75F5482F3297 Q30873726-84B6A368-4E76-4041-BABA-A77218B57EE7 Q33380457-9F7E7419-0B5D-4681-9823-63AC009DB942 Q33408560-9029C91E-DBF4-47DF-A3F3-036E6235E9AE Q33411822-F73DB634-B66C-4DCB-AAF6-2C942A3D4806 Q33632244-514E8418-58D9-4E13-8BB4-53A1EAE2ECFB Q33685495-983F9388-491C-4A05-8CDD-E152189772C0 Q33728470-7F8733AE-FA7B-4EE4-BB82-F1702BC2BDD7 Q33772867-B9514214-A645-40F4-AD9A-7B9E1CD26455 Q33866592-A208B96D-2362-4152-BBDF-E3A7B2200C2D Q33893161-44E90FE2-C84C-4DE1-8745-B4E7F64C08B2 Q33928765-6DED05BE-EFA6-43F6-A486-EB7E9ACA6F16 Q33940304-3350249E-C07E-4A31-84B7-ACDE46970938 Q34032827-0B31FAFE-549A-46E9-8A10-E8323D873FC2 Q34101036-4AD5C1C3-5D02-4399-BFC9-E766A20FFDE5 Q34152949-94296743-1DB0-4892-9581-164A43C8145E Q34356521-E54F8721-DDB5-4D53-B4B4-190F334A4C96 Q34428648-B343C891-1B91-4ED3-B9BB-3C7931CDC1CB Q34487555-0D720AA1-F081-46E8-A8A2-665206CAD9D6 Q34504770-B3506610-6DC8-41D5-B473-50F5D437146B Q34515880-922BFCE3-0AC2-4FD8-9169-DBC82B79B1F0 Q34837305-CC6461E9-1181-428A-9A19-23A1E9F3A61D

P2860

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

http://www.wikidata.org/entity/Q34015778

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The antitumor histone deacetyl ...... via suppression of cytokines.

@ast

The antitumor histone deacetyl ...... via suppression of cytokines.

@en

The antitumor histone deacetyl ...... via suppression of cytokines.

@nl

type

label

The antitumor histone deacetyl ...... via suppression of cytokines.

@ast

The antitumor histone deacetyl ...... via suppression of cytokines.

@en

The antitumor histone deacetyl ...... via suppression of cytokines.

@nl

prefLabel

The antitumor histone deacetyl ...... via suppression of cytokines.

@ast

The antitumor histone deacetyl ...... via suppression of cytokines.

@en

The antitumor histone deacetyl ...... via suppression of cytokines.

@nl

P1433

Q34015778-6A37AA3E-17D3-4796-AB59-B6BC7F0AFD4F

P1476

Q34015778-BB194492-C50A-4966-A1A9-A2D72AE474B5

P2093

Q34015778-09D0D490-D7B3-4FC6-B340-EF9A0F130E1C

Q34015778-239C1C85-59F4-45CB-80B6-9186540376C8

Q34015778-37CE6FFB-7B40-44CA-BD7B-98CC432FD513

Q34015778-486BEB8D-4950-45E5-98AF-83F83E280931

Q34015778-777E75C3-4D8B-48B0-BF2D-ED66AFA5E8E4

Q34015778-88513219-1ADA-470C-9CCC-BC9354AC3017

Q34015778-8C647F88-457D-4A6D-B6F7-3FAFD4FC0074

Q34015778-A0D3D5E0-CC22-4BAD-9FD3-137C2417C1EC

Q34015778-AB60A829-8ED6-4314-83A6-836AC4C08F4E

Q34015778-B75D1C7E-E026-4B5E-B159-6FE89741D412

P2860

Q34015778-013E8F80-6788-4EE1-99EB-97A223390FF8

Q34015778-21A3699E-4BAC-4EE3-96C6-917768285B9C

Q34015778-23E3B3CE-2C8B-4A24-972B-8E422F67F60D

Q34015778-36271BB4-4FE3-4528-B512-E45C8ACB8AE5

Q34015778-430D5273-1D0F-4304-A722-67191C42C93E

Q34015778-4A98DE4B-F445-4726-86A2-6D4331BC3A5B

Q34015778-502A8AFE-B9FC-467A-A0CD-2BF158C2126F

Q34015778-55D55E53-C52B-4ACE-98F9-D61CBA43E025

Q34015778-5B189929-7552-45C9-892C-040B03E8EB14

Q34015778-5C47C5DB-14A4-4247-8D8E-1AB31E7D01B4

P304

Q34015778-FD400D52-081A-4874-9734-5F0017C6B1B6

P31

Q34015778-97D8251F-7FC8-4012-B14C-ED4FC17AF363

P356

Q34015778-1530110B-0EDB-41DF-A86C-665164E26390

P407

Q34015778-EBCE656F-AE48-4C7E-BF41-2B267680A45A

P433

Q34015778-A1D41F37-0E0F-4B28-B58C-1AD25A80C307

P478

Q34015778-A36655B2-0E43-457B-9CE0-36D3931B2DB7

P50

Q34015778-0B92A316-4A34-4ED5-AAC6-83B3612F938D

Q34015778-4867FE23-74C8-449B-BFA8-E69A2ED73387

Q34015778-718B3B47-775A-4649-8942-7DEF0276D6FC

Q34015778-7E7763D8-793B-43F2-86B2-05B2D62E7E31

Q34015778-D0E06445-82A2-45F2-8E1B-99CDA2455218

Q34015778-DF99C74C-0A8D-48D8-83EB-DD4CF85730E1

P577

Q34015778-1A85EF7F-5871-4FE9-A65D-13C0FE747AC6

P5875

Q34015778-DF5B31F6-02F1-48CC-ADA2-4A97B6D3D6B9

P698

Q34015778-1124DA22-949A-45EF-8B8F-A5A9AAC3230C

P932

Q34015778-140E5A20-E60C-44A0-99D9-77BD7FB22A75

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The antitumor histone deacetyl ...... via suppression of cytokines.

@en

P2093

Benjamin J Pomerantz

http://www.w3.org/2001/XMLSchema#string

Flavio Leoni

http://www.w3.org/2001/XMLSchema#string

Giancarlo Donà

http://www.w3.org/2001/XMLSchema#string

Gianluca Fossati

http://www.w3.org/2001/XMLSchema#string

Giorgio Bertolini

http://www.w3.org/2001/XMLSchema#string

Giulia Porro

http://www.w3.org/2001/XMLSchema#string

Igor Goncharov

http://www.w3.org/2001/XMLSchema#string

Leonid L Reznikov

http://www.w3.org/2001/XMLSchema#string

Paolo Mascagni

http://www.w3.org/2001/XMLSchema#string

Paolo Pagani

http://www.w3.org/2001/XMLSchema#string

P2860

The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth.

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

Duration of nuclear NF-kappaB action regulated by reversible acetylation

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

Altered cytokine production in mice lacking P2X(7) receptors

Biologic basis for interleukin-1 in disease

P304

2995-3000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.052702999

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Giamila Fantuzzi

Silvano Sozzani

Britta Siegmund

Charles A. Dinarello

P577

2002-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11493959

http://www.w3.org/2001/XMLSchema#string

P698

11867742

http://www.w3.org/2001/XMLSchema#string

P932

122461

http://www.w3.org/2001/XMLSchema#string